The Patent Finder

Noden Pharma Dac

Also on record
Records under this name other than the patents Noden Pharma Dac holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Noden Pharma Dac

PatentTitleStatus Expires Confidence
US 8,617,595Galenic Formulations of Organic Compounds
Term ended
Term ended Jul 2, 2026 · Medium confidence
Term endedTerm ended Jul 2, 2026Medium confidence
US 8,168,616Combination Comprising a Renin Inhibitor and an Angiotensin Receptor Inhibitor for Hypertension
Lapsed on the fee record
Ended May 1, 2024 · High confidence
Lapsed on the fee recordEnded May 1, 2024High confidence
US 8,183,295Pharmaceutical Composition Comprising a Renin Inhibitor, a Calcium Channel Blocker and a Diuretic
Term ended
Term ended May 16, 2023 · Medium confidence
Term endedTerm ended May 16, 2023Medium confidence
US 6,730,798Process for the preparation of substituted octanoyl amides
Term ended
Term ended Jan 18, 2023 · From the USPTO record
Term endedTerm ended Jan 18, 2023From the USPTO record
US 9,023,894Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases
Term ended
Term ended Sep 11, 2022 · Medium confidence
Term endedTerm ended Sep 11, 2022Medium confidence
US 9,023,893Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases
Term ended
Term ended Mar 3, 2022 · Medium confidence
Term endedTerm ended Mar 3, 2022Medium confidence
US 8,613,949Galenical Formulations of Organic Compounds
Lapsed on the fee record
Ended Dec 24, 2021 · High confidence
Lapsed on the fee recordEnded Dec 24, 2021High confidence
US 8,618,174Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Term ended
Ended no later than Nov 15, 2020 · From the USPTO record
Term endedEnded no later than Nov 15, 2020From the USPTO record
US 7,153,675Process for the preparation of substituted carboxylic esters
Lapsed on the fee record
Ended Dec 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2018From the USPTO record
US 7,132,569Preparation of N-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
Lapsed on the fee record
Ended Nov 7, 2018 · From the USPTO record
Lapsed on the fee recordEnded Nov 7, 2018From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited